$OSUR News

OraSure Technologies: Lack Of Near Term Catalysts

OraSure (OSUR) Q2 2026 Earnings Call Transcript

OraSure Technologies, Inc. Q2 2026 Earnings Call Summary

OraSure Technologies, Inc. (OSUR) Q2 2026 Earnings Call Transcript

OraSure Technologies Inc (OSUR) (Q2 2026) Earnings Call Highlights: Revenue Surges 9. ...

OraSure Technologies Q2 Earnings Call Highlights

OraSure Technologies (NASDAQ:OSUR) Q2 Beat Tempered by Soft Q3 Guidance

OraSure Announces Second Quarter 2026 Financial Results

OraSure Technologies Sees Q3 Sales $29.500M-$32.500M vs $31.143M Est

OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th

OraSure Receives Emergency Use Authorization for Second Generation Ebola Test

OraSure Technologies Receives FDA's Emergency Use Authorization For Its OraQuick Ebola 2.0 Rapid Antigen Test

OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections

OraSure Technologies Independent Director Acquires 195% More Stock

OraSure Technologies, Inc. Q1 2026 Earnings Call Summary

OraSure Technologies Q1 Earnings Call Highlights

OraSure Technologies, Inc. (OSUR) Q1 2026 Earnings Call Transcript

OraSure Technologies (NASDAQ:OSUR) Q1 2026 Results Meet Revenue Forecast but Losses Widen, Shares Dip

OraSure (OSUR) Q1 2026 Earnings Transcript

OraSure Announces First Quarter 2026 Financial Results